<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for ARRY</title>
    <link />
    <description>Headlines for Array BioPharma</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Array BioPharma's CEO Presents at 2013 UBS Global Life Sciences Conference (Transcript)</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1450481-array-biopharma-s-ceo-presents-at-2013-ubs-global-life-sciences-conference-transcript.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 21 May 2013 13:29:06 GMT</pubDate>
    </item>
    <item>
      <title>Array BioPharma's CEO Presents at Bank of America Merrill Lynch Healthcare Conference (Transcript)</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1441571-array-biopharma-s-ceo-presents-at-bank-of-america-merrill-lynch-healthcare-conference-transcript.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 16 May 2013 16:34:03 GMT</pubDate>
    </item>
    <item>
      <title>Part 3: Will Array BioPharma Become A Late Stage Biopharmaceutical Company?</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1438981-part-3-will-array-biopharma-become-a-late-stage-biopharmaceutical-company.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 16 May 2013 01:00:35 GMT</pubDate>
    </item>
    <item>
      <title>10 ASCO '13 Abstracts You Can Read Right Now</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11923326/1/10-asco-13-abstracts-you-can-read-right-now.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Wed, 15 May 2013 18:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Array Biopharma: Measuring The Strength Of This Small-Cap Pharma Stock</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1435851-array-biopharma-measuring-the-strength-of-this-small-cap-pharma-stock.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 15 May 2013 05:45:38 GMT</pubDate>
    </item>
    <item>
      <title>Array BioPharma's CEO Discusses Q3 2013 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1410361-array-biopharma-s-ceo-discusses-q3-2013-results-earnings-call-transcript.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 07 May 2013 15:32:07 GMT</pubDate>
    </item>
    <item>
      <title>Near-Term Catalysts And High Insider Ownership Make GTx An Attractive Buy</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1407291-near-term-catalysts-and-high-insider-ownership-make-gtx-an-attractive-buy.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 07 May 2013 09:01:00 GMT</pubDate>
    </item>
    <item>
      <title>Array's Up-Coming Value Enhancing Catalysts</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1346501-array-s-up-coming-value-enhancing-catalysts.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 17 Apr 2013 05:00:15 GMT</pubDate>
    </item>
    <item>
      <title>Array Presents ARRY-520 Data - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/96797/array-presents-arry-520-data.aspx</link>
      <author>Zacks</author>
      <pubDate>Wed, 10 Apr 2013 18:20:01 GMT</pubDate>
    </item>
    <item>
      <title>Gilead Seeks FDA Approval - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/96653/gilead-seeks-fda-approval.aspx</link>
      <author>Zacks</author>
      <pubDate>Tue, 09 Apr 2013 16:30:01 GMT</pubDate>
    </item>
    <item>
      <title>Regeneron Aims HQ Expansion - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/96558/regeneron-aims-hq-expansion.aspx</link>
      <author>Zacks</author>
      <pubDate>Mon, 08 Apr 2013 18:15:01 GMT</pubDate>
    </item>
    <item>
      <title>BMY Announces Management Changes - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/96549/bmy-announces-management-changes.aspx</link>
      <author>Zacks</author>
      <pubDate>Mon, 08 Apr 2013 16:53:01 GMT</pubDate>
    </item>
    <item>
      <title>R&amp;D and Iclusig Update from Ariad  - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/96448/rd-and-iclusig-update-from-ariad.aspx</link>
      <author>Zacks</author>
      <pubDate>Fri, 05 Apr 2013 17:50:01 GMT</pubDate>
    </item>
    <item>
      <title>Orphan Status for Insmed's Arikace - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/96329/orphan-status-for-insmeds-arikace.aspx</link>
      <author>Zacks</author>
      <pubDate>Thu, 04 Apr 2013 16:15:01 GMT</pubDate>
    </item>
    <item>
      <title>Array BioPharma Announces Updates on ARRY-520 Clinical Data at the 2013 International Myeloma Worksh</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/04/3471121/array-biopharma-announces-updates-on-arry-520-clinical-data-at-the-2013-internati.aspx</link>
      <author>Benzinga</author>
      <pubDate>Thu, 04 Apr 2013 08:33:40 GMT</pubDate>
    </item>
    <item>
      <title>BioMarin Files CTA for BMN-190 - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/96165/biomarin-files-cta-for-bmn-190.aspx</link>
      <author>Zacks</author>
      <pubDate>Wed, 03 Apr 2013 09:50:01 GMT</pubDate>
    </item>
    <item>
      <title>BMRN Seeks US Approval of Vimizim - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/96103/bmrn-seeks-us-approval-of-vimizim.aspx</link>
      <author>Zacks</author>
      <pubDate>Tue, 02 Apr 2013 16:15:01 GMT</pubDate>
    </item>
    <item>
      <title>4 Health Care Stocks Under $10 to Watch</title>
      <link>http://www.fool.com/news/xt/thestreet/www.stockpickr.com/4-health-care-stocks-under-10-watch.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Tue, 02 Apr 2013 14:36:00 GMT</pubDate>
    </item>
    <item>
      <title>ANTH's Blisibimod Enters Phase III - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/96029/anths-blisibimod-enters-phase-iii.aspx</link>
      <author>Zacks</author>
      <pubDate>Mon, 01 Apr 2013 18:35:01 GMT</pubDate>
    </item>
    <item>
      <title>Array BioPharma: An Exciting Year Ahead</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1305131-array-biopharma-an-exciting-year-ahead.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 28 Mar 2013 16:14:23 GMT</pubDate>
    </item>
  </channel>
</rss>
